{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:33:36Z","timestamp":1762032816772},"reference-count":31,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.vaccine.2009.03.011","type":"journal-article","created":{"date-parts":[[2009,3,14]],"date-time":"2009-03-14T10:23:01Z","timestamp":1237026181000},"page":"2775-2780","source":"Crossref","is-referenced-by-count":21,"title":["Small protective fragments of the Yersinia pestis V antigen"],"prefix":"10.1016","volume":"27","author":[{"given":"Claire","family":"Vernazza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bry","family":"Lingard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen C.","family":"Flick-Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie W.J.","family":"Baillie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen S.","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.03.011_bib1","unstructured":"World Health Organisation. Factsheet\u2014Plague. WWW 2005 [cited 2008 Jan 8]. Available from: URL: http:\/\/www.who.int\/mediacentre\/factsheets\/fs267\/en\/."},{"key":"10.1016\/j.vaccine.2009.03.011_bib2","first-page":"653","article-title":"Effectiveness of live or killed plague vaccines in man","volume":"42","author":"Meyer","year":"1970","journal-title":"Bull World Health Organ"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2009.03.011_bib3","first-page":"85","article-title":"Plague immunization. II. Relation of Adverse clinical reactions to multiple immunizations with killed vaccine","volume":"129","author":"Marshal","year":"1974","journal-title":"J Infect Dis"},{"issue":"July (15)","key":"10.1016\/j.vaccine.2009.03.011_bib4","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0264-410X(96)00303-9","article-title":"A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague","author":"Williamson","year":"1997","journal-title":"Vaccine"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2009.03.011_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/infdis\/129.Supplement_1.S41","article-title":"Plague immunization VI. Vaccination with the fraction1 antigen of Yersinia pestis","volume":"129","author":"Meyer","year":"1974","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2009.03.011_bib6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4269\/ajtmh.1990.43.389","article-title":"Recombinant capsular antigen (fraction-1) from Yersinia-Pestis induces a protective antibody-response in Balb\/C mice","volume":"43","author":"Simpson","year":"1990","journal-title":"Am J Trop Med Hyg"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2009.03.011_bib7","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/IAI.64.11.4580-4585.1996","article-title":"Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis","volume":"64","author":"Anderson","year":"1996","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2009.03.011_bib8","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1128\/IAI.63.8.2854-2858.1995","article-title":"Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague","volume":"63","author":"Leary","year":"1995","journal-title":"Infect Immun"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2009.03.011_bib9","first-page":"3598","article-title":"Human immune response to a plague vaccine comprising recombinant F1 and V antigens","volume":"73","author":"Williamson","year":"2006","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2009.03.011_bib10","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1021\/bp050098r","article-title":"Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague","volume":"21","author":"Powell","year":"2005","journal-title":"Biotechnol Prog"},{"issue":"17","key":"10.1016\/j.vaccine.2009.03.011_bib11","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1128\/JB.183.17.5082-5091.2001","article-title":"LcrG-LcrV interaction is required for control of yops secretion in Yersinia pestis","volume":"183","author":"Matson","year":"2001","journal-title":"J Bacteriol"},{"issue":"5748","key":"10.1016\/j.vaccine.2009.03.011_bib12","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.1118476","article-title":"The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles","volume":"310","author":"Mueller","year":"2005","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.vaccine.2009.03.011_bib13","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/j.1365-2958.2007.05871.x","article-title":"Function and molecular architecture of the Yersinia injectisome tip complex","volume":"65","author":"Broz","year":"2007","journal-title":"Mol Microbiol"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2009.03.011_bib14","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1128\/IAI.65.4.1196-1203.1997","article-title":"Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: amplification of interleukin-10","volume":"65","author":"Nedialkov","year":"1997","journal-title":"Infect Immun"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2009.03.011_bib15","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.chom.2008.09.004","article-title":"Toll-Like receptor 6 drives differentiation of tolerogenic dendritic cells and contributes to LcrV-mediated plague pathogenesis","volume":"4","author":"DePaolo","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2009.03.011_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.micpath.2006.09.003","article-title":"Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates","volume":"42","author":"Williamson","year":"2007","journal-title":"Microb Pathog"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2009.03.011_bib17","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1128\/IAI.62.10.4192-4201.1994","article-title":"Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A\u2013V antigen fusion peptide","volume":"62","author":"Motin","year":"1994","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2009.03.011_bib18","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1128\/IAI.65.2.446-451.1997","article-title":"Passive immunity to infection with Yersinia spp. mediated by anti-recombinant V antigen is dependent on polymorphism of V antigen","volume":"65","author":"Roggenkamp","year":"1997","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2009.03.011_bib19","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1128\/IAI.65.11.4476-4482.1997","article-title":"Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization","volume":"65","author":"Hill","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.03.011_bib20","first-page":"301","article-title":"The structure of Yersinia pestis V-antigen, an essential virulence factor and mediator of immunity against plague","volume":"12","author":"Derewenda","year":"2004","journal-title":"Structure"},{"issue":"23\u201324","key":"10.1016\/j.vaccine.2009.03.011_bib21","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1016\/S0264-410X(02)00232-3","article-title":"Co-immunisation with a plasmid DNA cocktail primes mice against anthrax and plague","volume":"20","author":"Williamson","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.03.011_bib22","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1016\/j.vaccine.2004.02.036","article-title":"A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague","volume":"22","author":"Wang","year":"2004","journal-title":"Vaccine"},{"issue":"September (25\u201326)","key":"10.1016\/j.vaccine.2009.03.011_bib23","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1016\/S0264-410X(03)00362-1","article-title":"Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus","volume":"21","author":"Riemenschneider","year":"2003","journal-title":"Vaccine"},{"issue":"October (41)","key":"10.1016\/j.vaccine.2009.03.011_bib24","doi-asserted-by":"crossref","first-page":"38714","DOI":"10.1074\/jbc.M203632200","article-title":"Interactions of the Type III secretion pathway proteins LcrV and LcrG from Yersinia pestis are mediated by coiled-coil domains","volume":"277","author":"Lawton","year":"2002","journal-title":"J Biol Chem"},{"issue":"June (5)","key":"10.1016\/j.vaccine.2009.03.011_bib25","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1046\/j.1365-2958.1999.01408.x","article-title":"The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation","volume":"32","author":"Pettersson","year":"1999","journal-title":"Mol Microbiol"},{"issue":"November (7\u20138)","key":"10.1016\/j.vaccine.2009.03.011_bib26","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0264-410X(99)00317-5","article-title":"Gene gun mediated vaccination is superior to manual delivery for immunisation with DNA vaccines expressing protective antigens from Yersinia pestis or Venezuelan Equine Encephalitis virus","volume":"18","author":"Bennett","year":"1999","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2009.03.011_bib27","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0264-410X(95)00090-N","article-title":"A comparison of plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model","volume":"13","author":"Russell","year":"1995","journal-title":"Vaccine"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2009.03.011_bib28","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0264-410X(97)00249-1","article-title":"Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse","volume":"16","author":"Eyles","year":"1998","journal-title":"Vaccine"},{"issue":"December (26)","key":"10.1016\/j.vaccine.2009.03.011_bib29","doi-asserted-by":"crossref","first-page":"14626","DOI":"10.1073\/pnas.94.26.14626","article-title":"DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity","volume":"94","author":"Boyle","year":"1997","journal-title":"Proc Natl Acad Sci"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2009.03.011_bib30","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.4049\/jimmunol.162.4.2291","article-title":"Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria","volume":"162","author":"Elkins","year":"1999","journal-title":"J Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2009.03.011_bib31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.immuni.2005.01.009","article-title":"A Roadmap for the immunomics of category A\u2013C pathogens","volume":"22","author":"Sette","year":"2005","journal-title":"Immunity"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09003788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09003788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T12:43:50Z","timestamp":1684932230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09003788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":31,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0264410X09003788"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.03.011","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}